Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Omega-3 wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
7 of 7 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Bromelain and Omega-3 have evidence — compare verdict strength side-by-side.
500-2000mg (measured in GDU — aim for 2000-3000 GDU)
On empty stomach for systemic effects, With meals for digestive effects
Capsules standardized to GDU (gelatin digesting units)
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
3-7 days
1-2 weeks
3-7 days
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Exploring the Therapeutic Potential of Bromelain: Applications, Benefits, and Mechanisms
Nutrients (2024) · Systematic review
It has a long history of traditional medicinal use in various cultures, particularly in Central and South America, where pineapple is native.
Bromelain as a natural anti-inflammatory drug: a systematic review
Natural product research (2025) · Systematic review
Among these compounds, bromelain is highlighted, as a cysteine protease isolated from the Ananas comosus (pineapple) stem.
Bromelain and liver health: A comprehensive systematic review of preclinical studies
Clinical nutrition ESPEN (2025) · Systematic review
Our research suggests that bromelain possesses both prophylactic and curative qualities in terms of liver damage, as supported by its ability to decrease enzyme levels, enhance liver structure, reduce oxidative stress markers, and regulate lipid metabolism.
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Based on meta-analysis showing statistically significant but modest pain reduction (mean difference -0.27). Effect size was small and studies showed moderate heterogeneity.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 5.5/10) and wins in 2 of 3 categories.
For reduce inflammation, Omega-3 has a higher relevance score (90 vs 75).
No known interactions between Bromelain and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.